Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1

XW03351 ICD10-PCS Code is a billable and specific code that can be used to indicate the procedure of Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1 for reimbursement purposes. The 2023 edition of the American ICD-10-PCS code became effective on October 1, 2022.

Short description for XW03351 ICD10-PCS code:

Introduce Blinatumomab in Periph Vein, Perc, New Tech 1